Zoom Video Communications Inc shares tumbled nearly 17 percent to close at $289.50 Tuesday after it experienced a faster-than-expected drop in demand, with its business plans becoming questionable as people return to the office.
The price drop was the most in over nine months for Zoom.
With the easing of the pandemic, Zoom will need new growth avenues.
Analysts expect Zoom to return to its true underlying growth rate after a few quarters.
Daiwa Capital noted that there are significant questions on how new customer demand will stabilize in the core business following the loosening of COVID-19 restrictions.
Zoom forecast its revenue this quarter to be between $1.015 billion and $1.020 billion, indicating a 31 percent raise, but less than the multiple-fold growth rates in 2020.
At least six brokerages reduced their price targets on Zoom, with Piper Sandler being the most bearish, slashing its price target by over $100 to $369, according to Refinitiv data.
Zoom's current capitalization is half of its peak in October at $175 billion.


Anthropic Revenue Surge Signals Strong AI Market Momentum in 2026
Nvidia Beats Earnings Expectations as AI Demand Drives Record Growth
Blackstone and Google Launch AI Cloud Venture, Pressuring CoreWeave and Nebius Shares
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Fed’s Anna Paulson Signals Rates Could Stay Higher Longer Amid Inflation Risks
Japan Manufacturing Growth Slows in May as Services Sector Stagnates Amid Rising Middle East Supply Costs
OpenAI Expands Globally with First Overseas AI Lab in Singapore
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026
Japan Airlines Signs 10-Year Boeing 787 Maintenance Deal With GE Aerospace
US Stock Futures Steady as Nvidia Earnings and Iran Tensions Keep Investors on Edge
New Zealand Budget 2026: Government Plans Major Public Service Job Cuts Ahead of Election
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
Gold Prices Climb as Trump Delays Iran Strike, Boosting Safe-Haven Demand
China to Buy 200 Boeing Jets, Push for Extended U.S. Trade Deal
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Samsung, Union Edge Closer to Deal as Strike Threat Looms 



